Lamzede

News
FDA gives green light to Chiesi's Lamzede

FDA gives green light to Chiesi's Lamzede

US regulators have approved Chiesi's Lamzede (velmanase alfa-tycv) as the first enzyme replacement therapy for the treatment of non-central nervous system manifestations of alpha-mannosidos